Development and internal and external validation of a nomogram model for predicting the risk of chronic kidney disease progression in IgA nephropathy patients
PeerJ · 2024
DOI: 10.7717/peerj.18416 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift PeerJ, 2024. Verfasst von Ying Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong, Sichuan, China. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Nomograms, Disease Progression, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Sichuan Provincial Department of Science and Technology Research Special Fund, Nanchong Science and Technology Plan Project.
Abstract (Originalsprache)
Background
IgA nephropathy (IgAN) is the most common primary glomerular disease in chronic kidney disease (CKD), exhibiting significant heterogeneity in both clinical and pathological presentations. We aimed to explore the risk factors influencing short-term prognosis (≥90 days) and to construct a nomogram model for evaluating the risk of CKD progression in IgAN patients.
Methods
Clinical and pathological data of patients diagnosed with IgAN through biopsy at two centers were retrospectively collected. Logistic regression was employed to analyze the training cohort dataset and identify the independent predictors to construct a nomogram model based on the final variables. The predictive model was validated both internally and externally, with its performance assessed using the area under the curve (AUC), calibration curves, and decision curve analysis.
Results
Out of the patients in the modeling group, 129 individuals (41.6%) did not achieve remission following 3 months of treatment, indicating a high risk of CKD progression. A multivariate logistic regression analysis demonstrated that body mass index, urinary protein excretion, and tubular atrophy/interstitial fibrosis were identified as independent predictors for risk stratification. A nomogram model was formulated utilizing the final variables. The AUCs for the training set, internal validation set, and external validation set were 0.746 (95% confidence intervals (CI) [0.691–0.8]), 0.764 (95% CI [0.68–0.85]), and 0.749 (95% CI [0.65–0.85]), respectively. The validation of the subgroup analysis also demonstrated a satisfactory AUC.
Conclusion
This study developed and validated a practical nomogram that can individually predict short-term treatment outcomes (≥90 days) and the risk of CKD progression in IgAN patients. It provides reliable guidance for timely and personalized intervention and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong, Sichuan, China.
- Department of Nephrology, Guangyuan Central Hospital, Guangyuan, Sichuan, China.
- Nanchong Key Laboratory of Basic and Clinical Research of Chronic Kidney Disease, Nanchong, Sichuan, China.
- Nanchong Clinical Medical Research Center, Nanchong, Sichuan, China.
Förderung
- The Sichuan Provincial Department of Science and Technology Research Special Fund
- Nanchong Science and Technology Plan Project
Zitieren
APA
Zhang, Y., Wang, Z., Tang, W., Yuan, X., & Xie, X. (2024). Development and internal and external validation of a nomogram model for predicting the risk of chronic kidney disease progression in IgA nephropathy patients. PeerJ. https://doi.org/10.7717/peerj.18416
Vancouver
Zhang Y, Wang Z, Tang W, Yuan X, Xie X. Development and internal and external validation of a nomogram model for predicting the risk of chronic kidney disease progression in IgA nephropathy patients. PeerJ. 2024. doi:10.7717/peerj.18416
BibTeX
@article{Zhang2024,
author = {Zhang, Ying and Wang, Zhixin and Tang, Wenwu and Yuan, Xinzhu and Xie, Xisheng},
title = {Development and internal and external validation of a nomogram model for predicting the risk of chronic kidney disease progression in IgA nephropathy patients},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.18416}
}
EUVIMED